Whether you are a resident, a young urologist or an experienced specialist, your career can benefit from an EAU Membership. The EAU supports you throughout your career with programmes for continuing medical education and certification. For young and upcoming EAU members we offer several educational programmes, scholarships and clinical visits. Members have advanced access to the Resource Centre.
For any successful clinician, having the most up-to-date evidence-based recommendations on hand is crucial for the successful treatment of your patients. The EAU Guidelines are unparalleled in that regard, used all across the world. They are comprehensively updated on an annual basis and freely accessible for all members.
Urologists are bound by national and, increasingly, international laws that govern treatment options and patient care. The EAU brings together the voices of medical professionals, researchers, innovators and patients on a European platform to keep urological topics on the agendas of the authorities.
The EAU offers a wide range of events and courses to interact with the best specialists in the field of urology. The Annual EAU Congress is the largest urology-related event in the world where you can network with like-minded professionals.
Our journal, European Urology, has been a prestigious urological forum for over 35 years, and is currently read by more than 20,000 urologists. It is one of the most widely-cited medical journals in the world and, with an impact factor of 17.581, leading in its field. Members have free access to full-text articles. Members also have access to European Urology Focus and European Urology Oncology.
Additionally, the independent EAU Research Foundation conducts clinical trials to add valuable data to the pool of scientific knowledge in Europe. Only as a member you are eligible to apply for grants and funding.
For almost 40 years the EAU has addressed the most pressing issues of urological care in Europe, through its scientific and educational initiatives, as well as its publications. Become a member and get access to the benefits:
Moderator of Plenary session 4 Renal Cell Carcinoma (RCC) Prof. Markus Kuczyk talked about if CARMENA trial changes everything.
Prof. Jens Bedke (DE) and Prof. Maria José Ribal discussed the primary results from SAUL study with Prof. Axel Merseburger.
Prof. van Moorselaar (NL) and Mr. Dowling (IE) gave insights of what urologists and patients can expect in Prostate Cancer treatment over the next year during the ESO Prostate Observatory at the 34th Annual EAU Congress in Barcelona.
EAU19 had an animated start on Saturday with Plenary Session 2; a ‘nightmare session’ on stones. Mr. Bertie Leigh (GB), veteran consultant solicitor, challenged some of Europe’s best stone surgeons on the troubling cases they presented.
Dr. Sanchez-Salas (FR) and Prof. Murphy (AU) discussed recent changes in the diagnostic pathway of clinically localized prostate cancer. In particular, the role of novel imaging techniques and biopsy approaches such as multiparametric MRI and MRI-targeted biopsy.
At the 34th Annual EAU Congress in Barcelona Prof. Van Poppel (BE) talked about the policy papers addressing the need to reconsider structured population-based PSA screening for prostate cancer.